183 related articles for article (PubMed ID: 34211766)
1. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome after high dose rate intracavitary brachytherapy with traditional point 'A' dose prescription in locally advanced carcinoma of uterine cervix: dosimetric analysis from the perspective of computed tomography imaging-based 3-dimensional treatment planning.
Dhabal S; Basu A; Sau S; Sau S; Maiti PK; Chakravarty A
Obstet Gynecol Sci; 2024 Jan; 67(1):67-75. PubMed ID: 37817413
[TBL] [Abstract][Full Text] [Related]
3. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
[TBL] [Abstract][Full Text] [Related]
4. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
5. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
6. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
7. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
9. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
Basu S; Manir KS; Basu A; Ghosh K
J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
Front Oncol; 2022; 12():841980. PubMed ID: 35372065
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
Palled SR; Tanvirpasha CAR; Naveen T; Sathiyan S; Kadirampatti G; Lokesh V
J Contemp Brachytherapy; 2019 Aug; 11(4):307-311. PubMed ID: 31523230
[TBL] [Abstract][Full Text] [Related]
12. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
13. Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes.
Rivera A; Wassel M; Brodin PN; Yaparpalvi R; Velten C; Kabarriti R; Garg M; Kalnicki S; Mehta KJ
J Contemp Brachytherapy; 2021 Apr; 13(2):158-166. PubMed ID: 33897789
[TBL] [Abstract][Full Text] [Related]
14. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
15. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination.
Hegazy N; Pötter R; Kirisits C; Berger D; Federico M; Sturdza A; Nesvacil N
Acta Oncol; 2013 Oct; 52(7):1345-52. PubMed ID: 23905674
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Computed Tomography-Guided Image-Based Interstitial Brachytherapy for Cancer of the Cervix Using GEC-ESTRO Guidelines.
Rishi KS; Alva RC; Kadam AR; Sharma S
Indian J Surg Oncol; 2018 Jun; 9(2):181-186. PubMed ID: 29887698
[TBL] [Abstract][Full Text] [Related]
18. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
19. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
20. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]